US Food and Drug Administration Black Box Warning and Its Impact on the Use of Erythropoiesis-Stimulating Agents: Thinking Outside the Box
J Clin Oncol
.
2017 Oct 1;35(28):3264.
doi: 10.1200/JCO.2017.74.3104.
Epub 2017 Aug 8.
Authors
Amer M Zeidan
1
,
Steven D Gore
1
,
Amy J Davidoff
1
Affiliation
1
Amer M. Zeidan, Steven D. Gore, and Amy J. Davidoff, Yale University, New Haven, CT.
PMID:
28787256
DOI:
10.1200/JCO.2017.74.3104
No abstract available
Publication types
Letter
Comment
MeSH terms
Drug Labeling
Erythropoiesis
Erythropoietin*
Hematinics*
Humans
United States
United States Food and Drug Administration
Substances
Hematinics
Erythropoietin